Clinical Trials URLs: The cohort included patients who underwent bariatric surgery at LABS clinical centers through 2009. August 15, 1950—The Omnibus Medical Research Act (P.L. December 21, 2000—The FY 2001 Consolidated Appropriations Act (P.L. 78-410. Following conclusion of the LABS-1 study, the LABS-2 study was initiated to examine the longer-term safety, outcomes, and durability of health changes of bariatric surgery. October 2007—Institute grantee Dr. Oliver Smithies shared the Nobel Prize in Physiology or Medicine with two other scientists for discovering principles for introducing specific gene modifications in mice by using embryonic stem cells. This funding supported a range of biomedical research efforts across the Institute's research mission. When traditional approaches for weight loss, such as diet, exercise, and medications, fail as effective treatments for obesity, bariatric surgical procedures that restrict stomach size or lead to altered absorption of nutrients may be performed. The intramural branches conduct basic, translational, and clinical biomedical research related to diabetes mellitus, endocrine, bone and metabolic diseases; digestive diseases, including liver diseases and nutritional disorders; kidney diseases; and hematologic diseases. We raised close to 40x our investment”! These documents present NIDDK’s scientific accomplishments and plans to public policy makers, including Congress; the scientific community; voluntary health organizations; and other audiences. At the time of the award, the scientists had been receiving continuous NIDDK grant support since 1951 and 1956, respectively. Participant outcomes were recorded post-operatively. Initial findings of the LABS-2 study show that patients with severe obesity who underwent bariatric surgery experienced substantial weight loss 3 years following the surgical procedure, with the majority experiencing maximum weight change during the first year. Randy W. Schekman and Thomas C. Südhof for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells. October 3, 2011—NIDDK grantee Dr. Bruce Beutler shared the Nobel Prize in Physiology or Medicine with NIH grantee Dr. Jules Hoffman for their discoveries concerning the activation of innate immunity. The Division of Diabetes, Endocrinology, and Metabolic Diseases supports research in. Urologic Interagency Coordinating Committee. The office provides strategic leadership, direction, oversight, and consultation on critical business and management operations and partners with the scientists and program staff in support of the NIDDK mission. November 20, 1985—The Health Research Extension Act of 1985 (P.L. The DEM's National Diabetes Data Group serves as the federal lead for collecting, analyzing, and sharing data on diabetes and its complications. Baruch S. Blumberg shared the Nobel Prize in Physiology or Medicine with another scientist for their research on infectious diseases. October 1977—In response to the recommendation of the National Commission on Diabetes, the National Diabetes Data Group was established within the Institute to collect, analyze, and disseminate diabetes data to scientific and public health policy and planning associations. In 2018 Dr. Rodgers was elected as a fellow to the American Association for the Advancement of Science and the Royal College of Physicians (London). 2264 and Senate report with S. 1061, FY 1998 appropriations bills for Labor/HHS/Education, urged NIH and NIDDK to establish a diabetes research working group to develop a comprehensive plan for NIH-funded diabetes research that would recommend future initiatives and directions. November 1970—The Institute celebrated its 20th anniversary. This report to Congress called for increased arthritis research and training programs, multipurpose arthritis centers, epidemiologic studies, and data systems in arthritis, a National Arthritis Information Service, and a National Arthritis Advisory Board. The primary objectives of the LABS-2 study were to determine weight, medical, surgical, and behavioral outcomes, including incidence and remission of co-morbid conditions, and to evaluate patient, procedure, and other characteristics that were associated with these outcomes. The NIDDK developed a plan to use its portion of the ARRA funds to meet the stimulus goals set forth in the Recovery Act. The National Commission on Diabetes, authorized by this act, was chartered on September 17, 1974. OCPL provides, Office of Scientific Program and Policy Analysis (OSPPA). ", Division of Digestive Diseases and Nutrition (DDN). April 19, 1977—The NIH director established a trans-NIH program for diabetes, with the NIAMDD taking lead responsibility. This funding program augments regularly appropriated funds HHS receives for diabetes research through the Labor-HHS-Education appropriations subcommittees. The Division of Diabetes, Endocrinology, and Metabolic Diseases provides research funding and support for basic and clinical research in the areas of type 1 and type 2 diabetes and other metabolic disorders, including cystic fibrosis; endocrinology and endocrine disorders; obesity, neuroendocrinology, and energy balance; and development, metabolism, and basic biology of liver, fat, and endocrine tissues. December 2011—The journal Science named an HIV-prevention research study led by NIDDK grantee Dr. Myron Cohen the 2011 Breakthrough of the Year. April 29, 2012—The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study results appeared in the New England Journal of Medicine, marking the first major comparative effectiveness trial for the treatment of type 2 diabetes in young people. April 16, 2015—The Medicare Access and CHIP Reauthorization Act of 2015 (P.L. April 1982—U.S. The law also established the National Commission on Digestive Diseases to investigate the incidence, duration, mortality rates, and social and economic impact of digestive diseases. Persons using assistive technology may not be able to fully access For a list of all NIDDK programs, including these, visit Research Programs and Contacts. 105-34), established a Special Statutory Funding Program for Type 1 Diabetes Research (now Section 330B of the Public Health Service Act). 93-354) was signed into law. He also co-leads the Illuminating the Druggable Genome program of the NIH Common Fund, and is a member of the NIH Steering Committee, NIH-Food and Drug Administration (FDA) Joint Leadership Council, and NIH-Centers for Medicare & Medicaid Services (CMS) Leadership Council, among others. June 1994—In response to congressional language, NIDDK established the Weight-control Information Network (WIN), an information service about obesity, weight management and nutrition. December 17, 2002—The Public Health Service Act amendment relating to diabetes research (P.L. The NIADDK was renamed the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). December 8, 2003—Title VII, Subtitle D, Section 733 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (P.L. November 15, 1950—The National Advisory Arthritis and Metabolic Diseases Council held its first meeting and recommended approval of NIAMD's first grants. June 1980—In response to congressional language, the NIDDK created the National Digestive Diseases Information Clearinghouse to increase knowledge and understanding about digestive diseases among people with these conditions and their families, health professionals, and the public. More recently, he and his collaborators have reported on a modified blood stem-cell transplant regimen that is highly effective in reversing sickle cell disease in adults and is associated with relatively low toxicity. The law provided $150 million per year for type 1 diabetes research in FY 2012 and FY 2013. Initial findings of the LABS-2 study have shown that patients with severe obesity who underwent bariatric surgery experienced substantial weight loss 3 years following the surgical procedure, with the majority experiencing maximum weight change during the first year. 114-10) extended the Special Statutory Funding Program for Type 1 Diabetes Research. October 1976—Dr. November 1, 1993—The functions of the NIH Division of Nutrition Research Coordination, including those of the NIH Nutrition Coordinating Committee, were transferred to the NIDDK., The Division of Kidney, Urologic, and Hematologic Diseases provides research funding and support for basic, translational, and clinical research studies of the kidney, urinary tract, and disorders of the blood and blood-forming organs. In addition, it reauthorized advisory boards for arthritis and diabetes research. 1961—Laboratory-equipped mobile trailer units began an epidemiological study of arthritis among the Blackfeet and Pima Indians in Montana and Arizona, respectively. He has been honored with many named lectureships at American medical centers and has published more than 250 original research articles, reviews, and book chapters; has edited four books and monographs; and holds three patents.